DMAAR - Drugs Made In America Acquisition Corp Rights Stock Price & Dividend Safety Sector: Financial Services | Exchange: NASDAQ Global Select Current Price & Safety Score Price: 0.11 USD StockBonds Safety Grade: Altman Z-Score (Bankruptcy Risk): 23.37 StockBond Score: -3.33 Company Description Drugs Made In America Acquisition Corp DMAAR is a special purpose acquisition company SPAC established with the primary objective of identifying and acquiring one or more active businesses or their assets The company plans to achieve these acquisitions through various transactional structures including mergers exchanges of equity shares direct asset purchases stock acquisitions or broader corporate reorganizations